Concord Biotech advanced 1.56% to Rs 1808.55 as value buying emerged at lower level. The scrip had declined 15.63% in seven sessions to end at Rs 1,780.75 yesterday, from its recent closing high of Rs ...

A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch ...

Legislation that aims to prevent preventable deaths from tuberculosis infection is one step closer to becoming law.

For example, the food additive azodicarbonamide, known as ADA and used as a bleaching agent in cereal flours, is included on ...